Patents by Inventor Abhilash Patangay
Abhilash Patangay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9066659Abstract: Patient posture information can be received, such as to indicate a change in patient posture by at least a threshold amount. A transient response signal indicative of a change in a physiological parameter can be received at multiple instances near a change in patient posture. Waveform morphology features can be extracted from a transient response signal and used to provide an indication of a cardiac status, such as a heart failure status.Type: GrantFiled: April 2, 2012Date of Patent: June 30, 2015Assignee: Cardiac Pacemakers, Inc.Inventors: Pramodsingh Hirasingh Thakur, Abhilash Patangay, John D. Hatlestad, Kenneth C. Beck
-
Patent number: 9049981Abstract: A system and method provide heart sound tracking, including an input circuit, configured to receive heart sound information, and a heart sound recognition circuit. The heart sound recognition circuit can be coupled to the input circuit and can be configured to recognize, within a particular heart sound of a particular heart sound waveform, a first intra heart sound energy indication and a corresponding first intra heart sound time indication using the heart sound information from the particular heart sound waveform and the heart sound information from at least one other heart sound waveform. The particular heart sound can include at least a portion of one of S1, S2, S3, and S4. Further, the first intra heart sound energy indication and the corresponding first intra heart sound time indication can correspond to the at least a portion of one of S1, S2, S3, and S4, respectively.Type: GrantFiled: December 7, 2012Date of Patent: June 9, 2015Assignee: Cardiac Pacemakers, Inc.Inventors: Abhilash Patangay, Krzysztof Z. Siejko, Gerrard M. Carlson
-
Publication number: 20150126886Abstract: A cardiac rhythm management system provides for ambulatory monitoring of hemodynamic performance based on quantitative measurements of heart sound related parameters for diagnostic and therapeutic purposes. Monitoring of such heart sound related parameters allows the cardiac rhythm management system to determine a need for delivering a therapy and/or therapy parameter adjustments based on conditions of a heart. This monitoring also allows a physician to observe or assess the hemodynamic performance for diagnosing and making therapeutic decisions. Because the conditions of the heart may fluctuate and may deteriorate significantly between physician visits, the ambulatory monitoring, performed on a continuous or periodic basis, ensures a prompt response by the cardiac rhythm management system that may save a life, prevent hospitalization, or prevent further deterioration of the heart.Type: ApplicationFiled: January 12, 2015Publication date: May 7, 2015Inventors: Abhilash Patangay, Krzysztof Z. Siejko
-
Publication number: 20150065819Abstract: A differential or relative measurement between an orthogonal measurement vector and another measurement vector can be used to determine the location where fluid accumulation is occurring or the local change in such fluid accumulation. This can help diagnose or treat infection or hematoma or seroma at a pocket of an implanted cardiac rhythm management device, other implanted medical device, or prosthesis. It can also help diagnose or treat pulmonary edema, pneumonia, pulmonary congestion, pericardial effusion, pericarditis, pleural effusion, hemodilution, or another physiological condition.Type: ApplicationFiled: November 11, 2014Publication date: March 5, 2015Inventors: Pramodsingh Hirasingh Thakur, Abhilash Patangay, Kent Lee
-
Patent number: 8972008Abstract: A system and method provide for systolic interval analysis. In an example, an implantable device measures a cardiac impedance signal. A transformation of the cardiac impedance interval is generated. The device also measures a heart sound signal. A time interval between a point on the transformed signal of the cardiac impedance signal and a point on the heart sound signal is calculated.Type: GrantFiled: January 25, 2013Date of Patent: March 3, 2015Assignee: Cardiac Pacemakers, Inc.Inventors: Abhilash Patangay, Krzysztof Z. Siejko, Gerrard M. Carlson, Loell Boyce Moon
-
Patent number: 8951203Abstract: Systems and methods include obtaining a measure of cardiac contractility. A cardiac contractility variability is determined from the measure of cardiac contractility. Analyzing the cardiac contractility variability, an indication of cardio-vasculature health is provided.Type: GrantFiled: April 15, 2010Date of Patent: February 10, 2015Assignee: Cardiac Pacemakers, Inc.Inventors: Abhilash Patangay, Yi Zhang, Aaron Lewicke, Julie A. Thompson
-
Patent number: 8951205Abstract: A cardiac rhythm management system provides for ambulatory monitoring of hemodynamic performance based on quantitative measurements of heart sound related parameters for diagnostic and therapeutic purposes. Monitoring of such heart sound related parameters allows the cardiac rhythm management system to determine a need for delivering a therapy and/or therapy parameter adjustments based on conditions of a heart. This monitoring also allows a physician to observe or assess the hemodynamic performance for diagnosing and making therapeutic decisions. Because the conditions of the heart may fluctuate and may deteriorate significantly between physician visits, the ambulatory monitoring, performed on a continuous or periodic basis, ensures a prompt response by the cardiac rhythm management system that may save a life, prevent hospitalization, or prevent further deterioration of the heart.Type: GrantFiled: January 24, 2013Date of Patent: February 10, 2015Assignee: Cardiac Pacemakers, Inc.Inventors: Abhilash Patangay, Krzysztof Z. Siejko
-
Patent number: 8954138Abstract: A patient QRS duration can be received or determined, such as using one or more patient physiological sensors. A portion of the QRS duration can be determined, such as a right or left ventricular activation time. In an example, the right ventricular activation time can be determined by identifying an onset of a QRS complex and an R-wave peak in the QRS complex. In an example, when the QRS duration exceeds a threshold duration, and the RV activation time does not exceed a second threshold duration, an indication of a cardiac conduction dysfunction can be provided, such as for discriminating between left bundle branch block and right bundle branch block.Type: GrantFiled: November 15, 2012Date of Patent: February 10, 2015Assignee: Cardiac Pacemakers, Inc.Inventors: Barun Maskara, Shibaji Shome, Pramodsingh Hirasingh Thakur, Abhilash Patangay
-
Patent number: 8900140Abstract: A differential or relative measurement between an orthogonal measurement vector and another measurement vector can be used to determine the location where fluid accumulation is occurring or the local change in such fluid accumulation. This can help diagnose or treat infection or hematoma or seroma at a pocket of an implanted cardiac rhythm management device, other implanted medical device, or prosthesis. It can also help diagnose or treat pulmonary edema, pneumonia, pulmonary congestion, pericardial effusion, pericarditis, pleural effusion, hemodilution, or another physiological condition.Type: GrantFiled: October 26, 2010Date of Patent: December 2, 2014Assignee: Cardiac Pacemakers, Inc.Inventors: Pramodsingh Hirasingh Thakur, Abhilash Patangay, Kent Lee
-
Patent number: 8858448Abstract: A device can include at least a first physiologic sensor circuit configured to provide a first physiologic signal, a second physiologic sensor circuit configured to provide a second physiologic signal, and a processor circuit. The processor circuit includes a principal component analysis circuit configured to represent data determined from the at least first and second physiologic sensor circuits as at least first and second axes, respectively, in a multidimensional space, determine one or more principal components in the multidimensional space, determine a quantitative attribute of the first and the second physiologic signals using at least one of the determined principal components or a projection of the data along the at least one determined principal component, and provide an indication of heart failure status according to the quantitative attribute to at least one of a user or a process.Type: GrantFiled: December 14, 2011Date of Patent: October 14, 2014Assignee: Cardiac Pacemakers, Inc.Inventors: Pramodsingh Hirasingh Thakur, Abhilash Patangay, Ramesh Wariar, John D. Hatlestad, Yi Zhang
-
Patent number: 8838240Abstract: Systems and methods provide for sensing, during an event of tachycardia, hemodynamic signals concurrently from at least two spatially separated locations within a patient, and quantifying a spatial relationship between the hemodynamic signals. Hemodynamic stability or state of the patient during the tachycardia event is determined based at least in part on the quantified spatial relationship. One or more anti-tachycardia therapies to treat the tachycardia may be selected based at least in part on the determined stability or state of patient hemodynamics, and the selected one or more anti-tachycardia therapies may be delivered to treat the tachycardia. The hemodynamic signals may comprise at least two, or a mixed combination, of cardiac impedance signals, cardiac chamber pressure signals, arterial pressure signals, heart sounds; and acceleration signals.Type: GrantFiled: September 10, 2008Date of Patent: September 16, 2014Assignee: Cardiac Pacemakers Inc.Inventors: Dan Li, Krzysztof Siejko, Abhilash Patangay
-
Patent number: 8821404Abstract: Physiological data, such as thoracic impedance data, can be obtained over a first time window to establish a baseline, or can be used to form one or more data clusters. Additional physiological data, such as thoracic impedance test data acquired over a later time window, can be obtained and compared to the baseline or data clusters to determine an indication of worsening heart failure. In an example, a quantitative attribute of one or more data clusters can be monitored and used to provide an indication of worsening heart failure. A posture discrimination metric can be obtained, such as using the physiological data obtained over the first time window. The additional physiological data, such as can be obtained over a second time window, can be compared to the posture discrimination metric to provide a patient posture status.Type: GrantFiled: December 13, 2011Date of Patent: September 2, 2014Assignee: Cardiac Pacemakers, Inc.Inventors: Pramodsingh Hirasingh Thakur, Abhilash Patangay
-
Patent number: 8801624Abstract: This document discusses, among other things, a system comprising an implantable medical device (IMD) including an implantable heart sound sensor circuit configured to produce an electrical heart sound signal representative of a heart sound of a subject and a processor circuit. The processor circuit is coupled to the heart sound sensor circuit and includes a detection circuit, a heart sound feature circuit and a trending circuit. The detection circuit configured to detect a physiologic perturbation and the heart sound feature circuit is configured to identify a heart sound feature in the electrical signal. The processor circuit is configured to trigger the heart sound feature circuit in relation to a detected physiologic perturbation. The trending circuit is configured to trend the heart sound feature in relation to a recurrence of the physiologic perturbation. The processor circuit is configured to declare a change in a physiologic condition of the patient according to the trending.Type: GrantFiled: October 18, 2013Date of Patent: August 12, 2014Assignee: Cardiac Pacemakers, Inc.Inventors: Abhilash Patangay, Jeffrey E. Stahmann, Robert J. Sweeney
-
Patent number: 8805493Abstract: The health state of a subject is automatically evaluated or predicted using at least one implantable device. In varying examples, the health state is determined by sensing or receiving information about at least one physiological process having a circadian rhythm whose presence, absence, or baseline change is associated with impending disease, and comparing such rhythm to baseline circadian rhythm prediction criteria. Other chronobiological rhythms beside circadian may also be used. The baseline prediction criteria may be derived using one or more past physiological process observation of the subject or population of subjects in a non-disease health state. The prediction processing may be performed by the at least one implantable device or by an external device in communication with the implantable device. Systems and methods for invoking a therapy in response to the health state, such as to prevent or minimize the consequences of predicted impending heart failure, are also discussed.Type: GrantFiled: March 19, 2013Date of Patent: August 12, 2014Assignee: Cardiac Pacemakers, Inc.Inventors: Yi Zhang, John D. Hatlestad, Gerard M. Carlson, Yousufali Dalal, Marina V. Brockway, Kent Lee, Richard O. Kuenzler, Carlos Haro, Krzysztof Z. Siejko, Abhilash Patangay
-
Patent number: 8801636Abstract: An example method includes monitoring a first posture including a first lateral decubitus posture (LDP), recording a first LDP record based on the first LDP, computing a first posture trend based on the first LDP record and determining and providing a wellness indication based on the first posture trend.Type: GrantFiled: July 19, 2007Date of Patent: August 12, 2014Assignee: Cardiac Pacemakers, Inc.Inventors: Aaron Lewicke, John D. Hatlestad, Abhilash Patangay
-
Publication number: 20140207206Abstract: According to a system or method, information indicative of a cardiac depolarization signal can be obtained. Information indicative of an acoustic signal from an implantable acoustic sensor included as a portion of an implantable therapy device can be obtained. A feature indicative of an R wave can be identified from the information indicative of the cardiac depolarization signal, and a feature indicative of an S2 heart sound can be identified from the information indicative of the acoustic signal. A time interval between an instant corresponding to the feature indicative of the R wave and an instant corresponding to the feature indicative of the S2 heart sound can be determined. Using information about the determined time interval, an adjusted pacing therapy parameter can be provided for use in a pacing therapy to be provided by the implantable therapy device.Type: ApplicationFiled: March 25, 2014Publication date: July 24, 2014Applicant: Cardiac Pacemakers, Inc.Inventors: Abhilash Patangay, Krzysztof Z. Siejko, Gerrard M. Carlson, Loell Boyce Moon
-
Patent number: 8700149Abstract: Systolic timing intervals are measured in response to delivering pacing energy to a pacing site of a patient's heart. An estimate of a patient's acute response to cardiac resynchronization therapy (CRT) for the pacing site is determined using the measured systolic timing intervals. The estimate is compared to a threshold. The threshold preferably distinguishes between acute responsiveness and non-responsiveness to CRT for a patient population. An indication of acute responsiveness to CRT for the pacing site may be produced in response to the comparison.Type: GrantFiled: May 24, 2012Date of Patent: April 15, 2014Assignee: Cardiac Pacemakers, Inc.Inventors: Abhilash Patangay, Krzysztof Z. Siejko, Mohan Krishnan, Gerrard M. Carlson
-
Publication number: 20140046200Abstract: This document discusses, among other things, a system comprising an implantable medical device (IMD) including an implantable heart sound sensor circuit configured to produce an electrical heart sound signal representative of a heart sound of a subject and a processor circuit. The processor circuit is coupled to the heart sound sensor circuit and includes a detection circuit, a heart sound feature circuit and a trending circuit. The detection circuit configured to detect a physiologic perturbation and the heart sound feature circuit is configured to identify a heart sound feature in the electrical signal. The processor circuit is configured to trigger the heart sound feature circuit in relation to a detected physiologic perturbation. The trending circuit is configured to trend the heart sound feature in relation to a recurrence of the physiologic perturbation. The processor circuit is configured to declare a change in a physiologic condition of the patient according to the trending.Type: ApplicationFiled: October 18, 2013Publication date: February 13, 2014Applicant: Cardiac Pacemakers, Inc.Inventors: Abhilash Patangay, Jeffrey E. Stahmann, Robert J. Sweeney
-
Publication number: 20140031641Abstract: Devices and methods for improving the sensitivity and specificity of heart failure (HF) detection are described. The devices and methods can detect a HF status such as using physiological sensor data and external biomarker assays. An apparatus can comprise ambulatory physiological sensors that can provide a first HF status indicator and a second HF status indicator to a user. An external biomarker sensor can provide an amount of a biomarker present, such as an assay for B-type natriuretic peptide (BNP), which provides information about HF status. A processor circuit can switch from a first HF detection mode to a second detection mode such as in response to the information from the biomarker sensor. The first detection mode can detect HF status using the first HF status indicator, and the second detection mode can detect HF status using the second HF status indicator. The second detection mode can have a higher specificity than the first detection mode.Type: ApplicationFiled: September 30, 2013Publication date: January 30, 2014Applicant: Cardiac Pacemakers, Inc.Inventors: Pramodsingh Hirasingh Thakur, Abhilash Patangay, Craig Stolen, Timothy Meyer
-
Patent number: 8602996Abstract: Devices and methods for improving the sensitivity and specificity of heart failure (HF) detection are described. The devices and methods can detect a HF status such as using physiological sensor data and external biomarker assays. An apparatus can comprise ambulatory physiological sensors that can provide a first HF status indicator and a second HF status indicator to a user. An external biomarker sensor can provide an amount of a biomarker present, such as an assay for B-type natriuretic peptide (BNP), which provides information about HF status. A processor circuit can switch from a first HF detection mode to a second detection mode such as in response to the information from the biomarker sensor. The first detection mode can detect HF status using the first HF status indicator, and the second detection mode can detect HF status using the second HF status indicator. The second detection mode can have a higher specificity than the first detection mode.Type: GrantFiled: May 31, 2011Date of Patent: December 10, 2013Assignee: Cardiac Pacemakers, Inc.Inventors: Pramodsingh Hirasingh Thakur, Abhilash Patangay, Craig Stolen, Timothy Meyer